insights_auto
Why is MESO down 2.59%?
Dive Deeperchevron_right
MESO:NASDAQ
Mesoblast Ltd
$10.89
arrow_downward
-2.59%(-0.29) 1D
Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
$11.19
High
$11.44
Low
$10.87
Mkt. cap
1.46B
Avg. vol.
269.90K
Volume
192.70K
52-wk high
$21.49
52-wk low
$10.87
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
Open
$11.19
High
$11.44
Low
$10.87
Mkt. cap
1.46B
Avg. vol.
269.90K
Volume
192.70K
52-wk high
$21.49
52-wk low
$10.87
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
News stories
From web sources and news partners
Yahoo Finance
·
15 hours ago
Mesoblast Eyes Heart Failure Filing as Back Pain Trial and RYONCIL Expansion Advance
ad-hoc-news.de
·
1 day ago
Mesoblast stock outlines RYONCIL expansion and pipeline plans
Investing.com UK
·
3 days ago
Mesoblast at Bell Potter Healthcare Conference: pipeline, sales and filings By Investing.com
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOSilviu Itescu
Employees108
Founded2004
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemesoblast.com